Generalizing causal inferences from individuals in randomized trials to all trial-eligible individuals

Abstract

We consider methods for causal inference in randomized trials nested within cohorts of trial-eligible individuals, including those who are not randomized. We show how baseline covariate data from the entire cohort, and treatment and outcome data only from randomized individuals, can be used to identify potential (counterfactual) outcome means and average treatment effects in the target population of all eligible individuals. We review identifiability conditions, propose estimators, and assess the estimators' finite-sample performance in simulation studies. As an illustration, we apply the estimators in a trial nested within a cohort of trial-eligible individuals to compare coronary artery bypass grafting surgery plus medical therapy vs. medical therapy alone for chronic coronary artery disease.

References in corpus (3)

• External Validity: From Do-Calculus to Transportability Across Populations
• Comment: Performance of Double-Robust Estimators When ``Inverse Probability'' Weights Are Highly Variable
• Comment: Understanding OR, PS and DR

Cited by in corpus (10)

• A Review of Generalizability and Transportability
• Improving trial generalizability using observational studies
• Improving efficiency of inference in clinical trials with external control data
• Transportability without positivity: a synthesis of statistical and simulation modeling
• Effect heterogeneity and variable selection for standardizing causal effects to a target population
• Causal effect on a target population: a sensitivity analysis to handle missing covariates
• Generalizing trial evidence to target populations in non-nested designs: Applications to AIDS clinical trials
• Do-search -- a tool for causal inference and study design with multiple data sources
• A Generalizability Score for Aggregate Causal Effect
• Experiment-selector cross-validated targeted maximum likelihood estimator for hybrid RCT-external data studies